Literature DB >> 16837552

The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells.

Rebecca S Muraoka-Cook1, Melissa Sandahl, Carty Husted, Debra Hunter, Leah Miraglia, Shu-mang Feng, Klaus Elenius, H Shelton Earp.   

Abstract

Differentiation of mammary epithelium in vivo requires signaling through prolactin- and ErbB4/HER4-dependent mechanisms; how these pathways intersect is unknown. We show herein that HC11 mouse mammary cells undergo ErbB4-dependent lactational differentiation. Prolactin and the ErbB4 ligand HB-EGF each induced STAT5A activation, expression of lactogenic differentiation markers, and lumen formation in three-dimensional Matrigel cultures in HC11 cells. ErbB4 undergoes ligand-dependent transmembrane domain cleavage at Val-675, releasing a soluble 80-kDa intracellular domain (s80(HER4)) that localizes to nuclei; the physiological relevance of s80(HER4) is unknown. A HER4(V675A) mutant abolishing transmembrane cleavage impaired STAT5A activity, lactogenic gene expression, and lumen formation. Kinase-dead HER4(KD) was neither cleaved nor able to induce differentiation of HC11 cells. Without treating HC11 cells with prolactin or HB-EGF, s80(HER4) (expressed from a cDNA construct) localized to the nucleus, activated STAT5A, and induced three-dimensional lumen formation. Nuclear localization of exogenous s80(HER4) required intact kinase activity of s80(HER4), as did activation of STAT5A. In contrast, nuclear localization of s80(HER4) and STAT5A activation did not require the 16-amino acid region of the ErbB4 intracellular domain specific to the Cyt-1 isoform of ErbB4, and absent in the Cyt-2 isoform. These results suggest that s80(HER4) formation contributes to ErbB4-dependent differentiation of mammary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837552      PMCID: PMC1556387          DOI: 10.1091/mbc.e06-02-0101

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  35 in total

1.  Presenilin-dependent gamma-secretase-like intramembrane cleavage of ErbB4.

Authors:  Hahn-Jun Lee; Kwang-Mook Jung; Yang Z Huang; Lori B Bennett; Joanne S Lee; Lin Mei; Tae-Wan Kim
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

2.  Role of the ErbB-4 carboxyl terminus in gamma-secretase cleavage.

Authors:  Chang-Yuan Ni; Hongping Yuan; Graham Carpenter
Journal:  J Biol Chem       Date:  2002-11-25       Impact factor: 5.157

Review 3.  The reciprocal dance between cancer and development.

Authors:  Lewis A Chodosh
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

4.  Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers.

Authors:  R Srinivasan; C E Gillett; D M Barnes; W J Gullick
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

5.  Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.

Authors:  C I Sartor; H Zhou; E Kozlowska; K Guttridge; E Kawata; L Caskey; J Harrelson; N Hynes; S Ethier; B Calvo; H S Earp
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  Nuclear localization of EGF receptor and its potential new role as a transcription factor.

Authors:  S Y Lin; K Makino; W Xia; A Matin; Y Wen; K Y Kwong; L Bourguignon; M C Hung
Journal:  Nat Cell Biol       Date:  2001-09       Impact factor: 28.824

7.  gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase.

Authors:  C Y Ni; M P Murphy; T E Golde; G Carpenter
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

8.  Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways.

Authors:  Wenle Xia; Robert J Mullin; Barry R Keith; Lei-Hua Liu; Hong Ma; David W Rusnak; Gary Owens; Krystal J Alligood; Neil L Spector
Journal:  Oncogene       Date:  2002-09-12       Impact factor: 9.867

9.  c-erbB-3: a nuclear protein in mammary epithelial cells.

Authors:  Martin Offterdinger; Christian Schöfer; Klara Weipoltshammer; Thomas W Grunt
Journal:  J Cell Biol       Date:  2002-06-03       Impact factor: 10.539

10.  Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium.

Authors:  K Miyoshi; J M Shillingford; G H Smith; S L Grimm; K U Wagner; T Oka; J M Rosen; G W Robinson; L Hennighausen
Journal:  J Cell Biol       Date:  2001-11-12       Impact factor: 10.539

View more
  46 in total

Review 1.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

2.  The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis.

Authors:  Anjali Naresh; Ann D Thor; Susan M Edgerton; Kathleen C Torkko; Rakesh Kumar; Frank E Jones
Journal:  Cancer Res       Date:  2008-08-01       Impact factor: 12.701

Review 3.  Receptor tyrosine kinases in the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

Review 4.  HER4 intracellular domain (4ICD) activity in the developing mammary gland and breast cancer.

Authors:  Frank E Jones
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-05-13       Impact factor: 2.673

5.  ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis.

Authors:  Fenghua Zeng; Ming-Zhi Zhang; Amar B Singh; Roy Zent; Raymond C Harris
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

6.  Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.

Authors:  Jonathan W Haskins; Don X Nguyen; David F Stern
Journal:  Sci Signal       Date:  2014-12-09       Impact factor: 8.192

Review 7.  Trafficking of receptor tyrosine kinases to the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

Review 8.  Role of ErbB4 in breast cancer.

Authors:  Maria Sundvall; Kristiina Iljin; Sami Kilpinen; Henri Sara; Olli-Pekka Kallioniemi; Klaus Elenius
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-05-03       Impact factor: 2.673

Review 9.  ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer.

Authors:  David F Stern
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-05-03       Impact factor: 2.673

10.  Cell death or survival promoted by alternative isoforms of ErbB4.

Authors:  Maria Sundvall; Ville Veikkolainen; Kari Kurppa; Zaidoun Salah; Denis Tvorogov; E Joop van Zoelen; Rami Aqeilan; Klaus Elenius
Journal:  Mol Biol Cell       Date:  2010-10-13       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.